SM
AGN

Stephen Mandel’s Allergan plc AGN Stock Holding History

Stephen Mandel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,789,239
Closed -$480M – 42
2016
Q1 		$480M Buy
+1,789,239
New +$512M 2.39% 18
2015
Q4 		– Sell
-2,607,655
Closed -$709M – 58
2015
Q3 		$709M Buy
2,607,655
+309,689
+13% +$95.1M 2.89% 11
2015
Q2 		$697M Buy
2,297,966
+465,652
+25% +$139M 2.61% 15
2015
Q1 		$545M Buy
+1,832,314
New +$522M 2.06% 21
2014
Q4 		– Sell
-2,478,628
Closed -$598M – 60
2014
Q3 		$598M Hold
2,478,628
– – 2.34% 19
2014
Q2 		$553M Buy
2,478,628
+100,320
+4% +$20.8M 2.23% 19
2014
Q1 		$490M Buy
+2,378,308
New +$471M 2.13% 20

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Stephen Mandel's AGN Position: Q2 2016 in Review

Stephen Mandel sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 1,789,239 shares — an estimated $480M sold.

Stephen Mandel first reported a position in AGN in Q1 2014 and held it in 7 quarters. The position peaked at $709M in Q3 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Stephen Mandel reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Stephen Mandel sold 1,789,239 Allergan plc shares in Q2 2016, an estimated $480M.
  • Stephen Mandel first reported a position in Allergan plc in Q1 2014 and held it in 7 quarters.
  • Stephen Mandel's Allergan plc position peaked at $709M in Q3 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Lone Pine Capital's 13F filing for Q2 2016, filed 15 Aug 2016.